Navigation Links
Calorie Restriction May Prevent, Reduce Alzheimer’s Neuropatholog

A new study directed by Mount Sinai School of Medicine extends and strengthens the research that experimental dietary regimens// might halt or even reverse symptoms of Alzheimer’s Disease (AD). The study entitled “Calorie Restriction Attenuates Alzheimer’s Disease Type Brain Amyloidosis in Squirrel Monkeys” which has been accepted for publication and will be published in the November 2006 issue of the Journal of Alzheimer’s Disease, demonstrates the potential beneficial role of calorie restriction in AD type brain neuropathology in non-human primates. Restricting caloric intake may prevent AD by triggering activity in the brain associated with longevity.

“The present study strengthens the possibility that CR may exert beneficial effects on delaying the onset of AD- amyloid brain neuropathology in humans, similar to that observed in squirrel monkey and rodent models of AD,” reported Mount Sinai researcher Dr. Pasinetti and his colleagues, who published their study, showing how restricting caloric intake based on a low-carbohydrate diet may prevent AD in an experimental mouse model, in the July 2006 issue of the Journal of Biological Chemistry.

“This new breakthrough brings great anticipation for further human study of caloric restriction, for AD investigators and for those physicians who treat millions of people suffering with this disease” says Giulio Maria Pasinetti, M.D., Ph.D., Professor of Psychiatry and Neuroscience, Director of the Neuroinflammation Research Center at Mount Sinai School of Medicine and lead author of the study. “The findings offer a glimmer of hope that there may someday be a way to prevent and stop this devastating disease in its tracks.”

AD is a rapidly growing public health concern with potentially devastating effects. An estimated 4.5 million Americans have AD. Presently, there are no known cures or effective preventive strategies. While genetic factors are responsible in early-onset cases, they appear t o play less of a role in late-onset-sporadic AD cases, the most common form of AD.

In this new study, Dr. Pasinetti at Mount Sinai School of Medicine, in collaboration with Dr. Donald Ingram at the Laboratory of Experimental Gerontology, National Institute on Aging, NIH, maintained the Squirrel Monkeys on calorie restrictive or normal diets throughout their entire lifespan until they died of natural causes. The researchers found that ~30% calorie restriction resulted in reduced AD type amyloid neuropathology in the temporal cortex relative to control fed monkeys. The decreased AD type neuropathology correlated with increased longevity of related protein SIRT1, located in the same brain region that influences a variety of functions including aging related diseases.

Collectively, the study suggests that the investigation of calorie restriction in non-human primates may be a valuable approach towards understanding the role of calorie restriction in human AD pathology. The present study strengthens the possibility that calorie restriction may exert beneficial effects in delaying the onset of AD. The findings also elucidate the important relationship between the expression of longevity genes like SIRT1 in calorie restriction dietary regimens and mechanisms associated with the prevention of AD.

Source-Newswse
SRM
'"/>




Related medicine news :

1. A Reduction In Calories Found To Yield More Benefits
2. Counting Calories Might Be The Ideal Way To Stay Healthy
3. Consumers Becoming More Health Conscious Than Calorie Conscious
4. Robo-Dog To Monitor Your Calorie Intake
5. Ward Off Aging With A Low-Calorie Nutritional Diet
6. Burn Away Calories In Your Garden
7. Cut Calories to Age Gracefully
8. Stay Young By Cutting Down Calories
9. Doctors Suggest Tax on High Calorie Diet to Deter Intake
10. Starter Salads Keep Calories At Bay
11. Kids of Himachal Pradesh to get Calorie-rich Midday Meals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2016)... ... May 30, 2016 , ... Another ER facility operated by First ... 3960 Legacy Drive, Plano, TX and is open 24 hours daily. , First Choice ... a medical open house. The Jasper High School band entertained attendees and accepted First ...
(Date:5/28/2016)... ... May 28, 2016 , ... SuperCloset is proud to officially ... the day to day issues, struggles and obstacles veterans’ need to overcome in order ... Project provides active or retired military veteran(s) with a donated SuperCloset product based on ...
(Date:5/28/2016)... ... ... of the city where’s it’s easy to spot the neon lights of chains serving fast ... diners with a taste for real food. , On May 13, the Best ... urban casual restaurant focusing on dishes made by hand with wholesome, organic ingredients that are ...
(Date:5/27/2016)... Hampshire (PRWEB) , ... May 27, 2016 , ... ... care products, announced today that it has been recognized as one of the best ... parenthood. Badger was named as one of nine small businesses providing progressive benefits to ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... caregivers to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy ... trends and tech within the industry, from leading advocates, associations and industry leaders ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... Since its commercial introduction in ... life science tool for conducting genetic studies in a ... in its new report that the industry sits on ... by a range of new applications in the clinical ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the Human ...
(Date:5/25/2016)... , May 25, 2016 ... Market by Type (3D, 2D, 4D), by Therapeutic Area ... by End User (Medical Device Manufacturers, Hospitals/ Clinics) - ... the global Medical Animation Market for the forecast period ... reach USD 301.3 Million by 2021 from USD 117.3 ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology: